Form 4 for CYAB CYABRA, INC.

Accepted 2026-07-13 17:08:49 ET · period of report 2026-07-10 · accession 0001213900-26-077642 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-07-13 17:08	2026-07-10	CYAB	Shraga Ido	CTO	A - Grant	$0.00	+53.6K	894.2K	+6%	$0
DM	2026-07-13 17:08	2026-07-10	CYAB	Shraga Ido	CTO	P - Purchase	$0.475	+107.3K	107.3K	New	+$51.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-07-10	A	A	53,650	$0.00	894,199	D	—	—	(F1) On July 10, 2026, the Reporting Person purchased 53,650 shares of common stock, par value $0.0001 per share (the "Common Stock"), from the Issuer in a private placement transaction (the "Private Placement") at a purchase price of $0.435 per share.
2	Derivative	Common Stock Warrants (right to buy)	2026-07-10	P	A	53,650	$0.45	53,650	D	$0.45 · — to —	53,650 Common Stock	(F2) The Reporting Person purchased Series B warrants to purchase up to 53,650 shares of Common Stock (the "Series B Warrants") in the Private Placement. (F3) The Series B Warrants will become exercisable upon the receipt of the requisite stockholder approval. (F4) The Series B Warrants expire on the date that is twelve (12) months following the initial exercise date.
3	Derivative	Common Stock Warrants (right to buy)	2026-07-10	P	A	53,650	$0.5	107,300	D	$0.5 · — to —	53,650 Common Stock	(F5) The Reporting Person purchased Series A warrants to purchase up to 53,650 shares of Common Stock (the "Series A Warrants") in the Private Placement. (F6) The Series A Warrants will become exercisable upon the receipt of the requisite stockholder approval. (F7) The Series A Warrants expire five (5) years following the initial exercise date.